Company intelligence / Profile preview

Orion Biopharma Consulting

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Orion Biopharma Consulting is an independent consultancy led by Dr. Que Liu that provides expertise and guidance to pharmaceutical companies seeking to accelerate innovative compounds from clinical development through regulatory approval. The consultancy has supported projects in diverse therapeutic areas and played roles in due diligence and asset evaluation for licensing/acquisition deals such as EQRx’s acquisition of almonertinib from Hansoh Pharmaceutical.

Therapeutic areas: EndocrinologyRare DiseasesImmunologyGastroenterologyCardiovascularNeurology
Modalities: small moleculesgene therapybiologics
Industry: Consulting

Beyond the preview

Go deeper on Orion Biopharma Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orion Biopharma Consulting.

Explore the full profile